Under Secretary Lago To Visit Central Virginia’s Newest U.S. Government-Incentivized Investments

Apr 10, 2023 | In the News

Under Secretary Lago To Visit Central Virginia’s Newest U.S. Government-Incentivized Investments SOURCE International Trade Administration “In Petersburg, Under Secretary Lago will tour the newly constructed Civica Rx facility, a non-profit generic drug company...

Richmond Pharmaceutical Giant Phlow Raises $36 Million

Apr 6, 2023 | In the News

Richmond Pharmaceutical Giant Phlow Raises $36 Million SOURCE Richmond Times-Dispatch by Sean Jones “Richmond pharmaceutical company Phlow Corp. has closed on a $36.1 million fundraising round targeted at growing its research and development capabilities. The...

Activation Capital Gets $15M From State for Richmond Innovation Center, Medicine Manufacturing Initiative

Feb 15, 2023 | In the News

Activation Capital Gets $15M From State for Richmond Innovation Center, Medicine Manufacturing Initiative SOURCE Richmond Inno IMAGE Activation Capital “Virginia Gov. Glenn Youngkin on Tuesday announced $66.7 million in grant funding for life sciences projects...

Downtown Richmond Gets $10 Million Toward New Innovation Building

Feb 15, 2023 | In the News

Downtown Richmond Gets $10 Million Toward New Innovation Building SOURCE Richmond Times-Dispatch “Gov. Glenn Youngkin announced Tuesday that four biotechnology and pharmaceutical manufacturing efforts tied to the University of Virginia, Virginia Commonwealth...

Podcast: Can America Make Its Own Medicine Again?

Feb 13, 2023 | In the News

Podcast: Can America Make Its Own Medicine Again? SOURCEAlliance for American Manufacturing “The United States depends on China and India for some of its most critical medicines, but one Central Virginia organization is working to change that. Infused with more...

Utah-Based Nonprofit Set to Open $140M Insulin Plant in Petersburg

Feb 8, 2023 | In the News

Utah-Based Nonprofit Set to Open $140M Insulin Plant in Petersburg SOURCE Axios Richmond “Petersburg is at the center of a nonprofit’s push to lower sky-high insulin costs. What’s happening: Utah-based Civica Rx is in the final stages of building a $140 million...